Literature DB >> 8611438

Nasopharyngeal carcinoma: an EBV-associated tumour not significantly influenced by HIV-induced immunosuppression. The AIDS/Cancer Working Group.

M Melbye1, T R Coté, D West, L Kessler, R J Biggar.   

Abstract

We used a link between cancer (859,398 reports) and AIDS (50,050 reports) registries in the United States to study whether nasopharyngeal carcinoma (NPC) was increased in the population with AIDS. There was no indication of a significantly increased risk up to or after the AIDS diagnosis, which argues against progressively failing immunity being important in the development of this malignancy.

Entities:  

Mesh：

Year:  1996        PMID： 8611438      PMCID： PMC2075828          DOI： 10.1038/bjc.1996.194

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  14 in total

1.  Kaposi's sarcoma in recipients of renal transplants.

Authors:  A R Harwood; D Osoba; S L Hofstader; M B Goldstein; C J Cardella; M J Holecek; R Kunynetz; R A Giammarco
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

2.  EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.

Authors:  H zur Hausen; H Schulte-Holthausen; G Klein; W Henle; G Henle; P Clifford; L Santesson
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

3.  Risk of cancer in renal-transplant recipients.

Authors:  R Hoover; J F Fraumeni
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

4.  Immunodeficiency in humans as a risk factor in the development of malignancy.

Authors:  A H Filipovich; B D Spector; J Kersey
Journal:  Prev Med       Date:  1980-03       Impact factor: 4.018

Review 5.  Epstein-Barr virus and nasopharyngeal carcinoma.

Authors:  N Raab-Traub
Journal:  Semin Cancer Biol       Date:  1992-10       Impact factor: 15.707

6.  Cancer risk after renal transplantation in the Nordic countries, 1964-1986.

Authors:  S A Birkeland; H H Storm; L U Lamm; L Barlow; I Blohmé; B Forsberg; B Eklund; O Fjeldborg; M Friedberg; L Frödin
Journal:  Int J Cancer       Date:  1995-01-17       Impact factor: 7.396

7.  Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.

Authors:  L J Kinlen; A G Sheil; J Peto; R Doll
Journal:  Br Med J       Date:  1979-12-08

8.  The prevalence of cancer. Estimates based on the Connecticut Tumor Registry.

Authors:  A R Feldman; L Kessler; M H Myers; M D Naughton
Journal:  N Engl J Med       Date:  1986-11-27       Impact factor: 91.245

Review 9.  HIV infection and cancers other than non-Hodgkin lymphoma and Kaposi's sarcoma.

Authors:  C S Rabkin; W A Blattner
Journal:  Cancer Surv       Date:  1991

10.  High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group.

Authors:  M Melbye; T R Coté; L Kessler; M Gail; R J Biggar
Journal:  Lancet       Date:  1994-03-12       Impact factor: 79.321
View more
  3 in total

1.  Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States.

Authors:  Fatma M Shebl; Kishor Bhatia; Eric A Engels
Journal:  Int J Cancer       Date:  2010-05-15       Impact factor: 7.396

2.  A Review of Carcinomas Arising in the Head and Neck Region in HIV-Positive Patients.

Authors:  Bibianna Purgina; Liron Pantanowitz; Raja R Seethala
Journal:  Patholog Res Int       Date:  2011-05-10

Review 3.  Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses.

Authors:  Blossom Damania; Christian Münz
Journal:  FEMS Microbiol Rev       Date:  2019-03-01       Impact factor: 16.408
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.